Clinical Spectrum in a Family with Tropomyosin-Mediated Hypertrophic Cardiomyopathy and Sudden Death in Childhood

被引:3
|
作者
Makhoul, Majd [1 ]
Ackerman, Michael J. [2 ,3 ,4 ]
Atkins, Dianne L. [1 ]
Law, Ian H. [1 ]
机构
[1] Univ Iowa, Childrens Hosp, Dept Pediat Cardiol, Iowa City, IA USA
[2] Mayo Clin, Windland Smith Rice Sudden Death Genom Lab, Div Cardiovasc Dis, Dept Med, Rochester, MN USA
[3] Mayo Clin, Div Pediat Cardiol, Dept Pediat, Rochester, MN USA
[4] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN USA
关键词
Hypertrophic cardiomyopathy; Implantable cardioverter defibrillator; Sudden cardiac death; RISK STRATIFICATION; PREVENTION; AGE;
D O I
10.1007/s00246-010-9843-1
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
This report demonstrates variable clinical courses in several members of a family with tropomyosin-mediated hypertrophic cardiomyopathy (HCM) (L185R mutation). The index case was an 8-year-old girl who died from sudden cardiac death and was diagnosed with HCM on autopsy. Her father had minimal hypertrophy but had an implantable cardioverter defibrillator placed prophylactically with no appropriate shocks. Two brothers progressed from normal phenotype to HCM on follow-up, the younger with significant hypertrophy and the older with mild hypertrophy. They both had malignant arrhythmia courses with VF, which was terminated by ICD shock. In conclusion, family members with same genotype can have significantly variable phenotypes.
引用
收藏
页码:215 / 220
页数:6
相关论文
共 50 条
  • [31] Risk of sudden cardiac death in childhood hypertrophic cardiomyopathy: Time to solve the mystery
    Norrish, Gabrielle
    Kaski, Juan Pablo
    CARDIOGENETICS, 2018, 8 (01) : 1 - 3
  • [32] Role of Family History of Sudden Death in Risk Stratification and Prevention of Sudden Death With Implantable Defibrillators in Hypertrophic Cardiomyopathy
    Bos, J. Martijn
    Maron, Barry J.
    Ackerman, Michael J.
    Haas, Tammy S.
    Sorajja, Paul
    Nishimura, Rick A.
    Gersh, Bernard J.
    Ommen, Steve R.
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 106 (10): : 1481 - 1486
  • [33] Severe Autonomic Dysregulation in Tropomyosin Mutant Mice: A Possible Contributor to Arrhythmias and Sudden Death in Hypertrophic Cardiomyopathy
    Sabharwal, Rasna
    Weiss, Robert M.
    Zimmerman, Kathy
    Chapleau, Mark W.
    HYPERTENSION, 2009, 54 (04) : E85 - E85
  • [34] Genotype and Family History as Risk Markers of Sudden Cardiac Death in Hypertrophic Cardiomyopathy
    Sakhnini, Ali
    Montazeri, Mahdi
    Chow, Cindy
    Silver, Josh
    Saha, Sudipta
    Chan, Raymond
    Gollob, Michael
    Fan, Steve
    Rowin, Ethan
    Maron, Martin
    Rakowski, Harry
    Adler, Arnon
    CIRCULATION, 2024, 150
  • [35] SUDDEN-DEATH IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
    PALEEV, NR
    YANKOVSKAYA, MO
    MRAVYAN, SR
    KARDIOLOGIYA, 1992, 32 (02) : 101 - 103
  • [36] Predictors of sudden cardiac death in hypertrophic cardiomyopathy
    Maki, S
    Ikeda, H
    Muro, A
    Yoshida, N
    Shibata, A
    Koga, Y
    Imaizumi, T
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 82 (06): : 774 - 778
  • [37] Sudden death and hypertrophic cardiomyopathy - Authors' reply
    Elliott, P
    Poloniecki, J
    McKenna, W
    LANCET, 2001, 357 (9272): : 1975 - 1976
  • [38] SUDDEN-DEATH IN OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
    OVODOVA, NF
    KLINICHESKAYA MEDITSINA, 1984, 62 (11): : 60 - 62
  • [39] HYPERTROPHIC CARDIOMYOPATHY AND SUDDEN-DEATH - REPLY
    NICOD, P
    POLIKAR, R
    PETERSON, KL
    NEW ENGLAND JOURNAL OF MEDICINE, 1988, 319 (16): : 1092 - 1092
  • [40] Aborted sudden cardiac death in hypertrophic cardiomyopathy
    Maron, BJ
    Casey, SA
    Almquist, AK
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 1999, 10 (02) : 263 - 263